No abstract available
Publication types
-
Letter
-
Research Support, Non-U.S. Gov't
MeSH terms
-
ADP-ribosyl Cyclase 1 / biosynthesis*
-
ADP-ribosyl Cyclase 1 / genetics
-
Antibodies, Monoclonal / pharmacology*
-
Antigens, Neoplasm / biosynthesis*
-
Antigens, Neoplasm / genetics
-
Dose-Response Relationship, Drug
-
Drug Synergism
-
Gene Expression Regulation, Neoplastic / drug effects*
-
Histone Deacetylase Inhibitors / administration & dosage
-
Histone Deacetylase Inhibitors / pharmacology*
-
Humans
-
Hydroxamic Acids / administration & dosage
-
Hydroxamic Acids / pharmacology*
-
Indoles / administration & dosage
-
Indoles / pharmacology*
-
Membrane Glycoproteins / biosynthesis*
-
Membrane Glycoproteins / genetics
-
Multiple Myeloma / drug therapy*
-
Multiple Myeloma / genetics
-
Multiple Myeloma / metabolism
-
Neoplasm Proteins / biosynthesis
-
Neoplasm Proteins / genetics
-
Panobinostat
-
Signaling Lymphocytic Activation Molecule Family / biosynthesis
-
Signaling Lymphocytic Activation Molecule Family / genetics
-
Tumor Cells, Cultured
-
Up-Regulation / drug effects
Substances
-
Antibodies, Monoclonal
-
Antigens, Neoplasm
-
Histone Deacetylase Inhibitors
-
Hydroxamic Acids
-
Indoles
-
Membrane Glycoproteins
-
Neoplasm Proteins
-
SLAMF7 protein, human
-
Signaling Lymphocytic Activation Molecule Family
-
daratumumab
-
Panobinostat
-
CD38 protein, human
-
ADP-ribosyl Cyclase 1